Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 802
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Cell ; 187(17): 4713-4732.e19, 2024 Aug 22.
Article in English | MEDLINE | ID: mdl-38968937

ABSTRACT

Immune tolerance mechanisms are shared in cancer and pregnancy. Through cross-analyzing single-cell RNA-sequencing data from multiple human cancer types and the maternal-fetal interface, we found B7-H4 (VTCN1) is an onco-fetal immune tolerance checkpoint. We showed that genetic deficiency of B7-H4 resulted in immune activation and fetal resorption in allogeneic pregnancy models. Analogously, B7-H4 contributed to MPA/DMBA-induced breast cancer progression, accompanied by CD8+ T cell exhaustion. Female hormone screening revealed that progesterone stimulated B7-H4 expression in placental and breast cancer cells. Mechanistically, progesterone receptor (PR) bound to a newly identified -58 kb enhancer, thereby mediating B7-H4 transcription via the PR-P300-BRD4 axis. PR antagonist or BRD4 degrader potentiated immunotherapy in a murine B7-H4+ breast cancer model. Thus, our work unravels a mechanistic and biological connection of a female sex hormone (progesterone) to onco-fetal immune tolerance via B7-H4 and suggests that the PR-P300-BRD4 axis is targetable for treating B7-H4+ cancer.


Subject(s)
Immune Tolerance , Progesterone , Progestins , V-Set Domain-Containing T-Cell Activation Inhibitor 1 , Animals , Female , V-Set Domain-Containing T-Cell Activation Inhibitor 1/metabolism , Humans , Mice , Pregnancy , Progestins/pharmacology , Progestins/metabolism , Progesterone/metabolism , Breast Neoplasms/immunology , Breast Neoplasms/genetics , Breast Neoplasms/metabolism , Receptors, Progesterone/metabolism , Transcription Factors/metabolism , Cell Line, Tumor , CD8-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/metabolism , Mice, Inbred C57BL , Placenta/metabolism , Placenta/immunology
2.
Cell ; 187(18): 4905-4925.e24, 2024 Sep 05.
Article in English | MEDLINE | ID: mdl-38971151

ABSTRACT

Homologous recombination deficiency (HRD) is prevalent in cancer, sensitizing tumor cells to poly (ADP-ribose) polymerase (PARP) inhibition. However, the impact of HRD and related therapies on the tumor microenvironment (TME) remains elusive. Our study generates single-cell gene expression and T cell receptor profiles, along with validatory multimodal datasets from >100 high-grade serous ovarian cancer (HGSOC) samples, primarily from a phase II clinical trial (NCT04507841). Neoadjuvant monotherapy with the PARP inhibitor (PARPi) niraparib achieves impressive 62.5% and 73.6% response rates per RECIST v.1.1 and GCIG CA125, respectively. We identify effector regulatory T cells (eTregs) as key responders to HRD and neoadjuvant therapies, co-occurring with other tumor-reactive T cells, particularly terminally exhausted CD8+ T cells (Tex). TME-wide interferon signaling correlates with cancer cells upregulating MHC class II and co-inhibitory ligands, potentially driving Treg and Tex fates. Depleting eTregs in HRD mouse models, with or without PARP inhibition, significantly suppresses tumor growth without observable toxicities, underscoring the potential of eTreg-focused therapeutics for HGSOC and other HRD-related tumors.


Subject(s)
Neoadjuvant Therapy , Ovarian Neoplasms , Piperidines , Poly(ADP-ribose) Polymerase Inhibitors , T-Lymphocytes, Regulatory , Tumor Microenvironment , Female , Ovarian Neoplasms/drug therapy , Ovarian Neoplasms/pathology , Ovarian Neoplasms/immunology , Poly(ADP-ribose) Polymerase Inhibitors/therapeutic use , Poly(ADP-ribose) Polymerase Inhibitors/pharmacology , Humans , T-Lymphocytes, Regulatory/immunology , T-Lymphocytes, Regulatory/metabolism , T-Lymphocytes, Regulatory/drug effects , Animals , Mice , Neoadjuvant Therapy/methods , Tumor Microenvironment/drug effects , Piperidines/pharmacology , Piperidines/therapeutic use , Indazoles/therapeutic use , Indazoles/pharmacology , Homologous Recombination , CD8-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/metabolism , Cell Line, Tumor
3.
Nat Immunol ; 22(4): 460-470, 2021 04.
Article in English | MEDLINE | ID: mdl-33767425

ABSTRACT

Targeting the p53-MDM2 pathway to reactivate tumor p53 is a chemotherapeutic approach. However, the involvement of this pathway in CD8+ T cell-mediated antitumor immunity is unknown. Here, we report that mice with MDM2 deficiency in T cells exhibit accelerated tumor progression and a decrease in tumor-infiltrating CD8+ T cell survival and function. Mechanistically, MDM2 competes with c-Cbl for STAT5 binding, reduces c-Cbl-mediated STAT5 degradation and enhances STAT5 stability in tumor-infiltrating CD8+ T cells. Targeting the p53-MDM2 interaction with a pharmacological agent, APG-115, augmented MDM2 in T cells, thereby stabilizing STAT5, boosting T cell immunity and synergizing with cancer immunotherapy. Unexpectedly, these effects of APG-115 were dependent on p53 and MDM2 in T cells. Clinically, MDM2 abundance correlated with T cell function and interferon-γ signature in patients with cancer. Thus, the p53-MDM2 pathway controls T cell immunity, and targeting this pathway may treat patients with cancer regardless of tumor p53 status.


Subject(s)
CD8-Positive T-Lymphocytes/enzymology , Lymphocytes, Tumor-Infiltrating/enzymology , Neoplasms/enzymology , Proto-Oncogene Proteins c-mdm2/metabolism , STAT5 Transcription Factor/metabolism , Animals , Antineoplastic Agents/pharmacology , CD8-Positive T-Lymphocytes/drug effects , CD8-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/transplantation , Cell Line, Tumor , Combined Modality Therapy , Female , Gene Expression Regulation, Neoplastic , HEK293 Cells , Humans , Immunotherapy, Adoptive , Lymphocytes, Tumor-Infiltrating/drug effects , Lymphocytes, Tumor-Infiltrating/immunology , Lymphocytes, Tumor-Infiltrating/transplantation , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Transgenic , Neoplasms/genetics , Neoplasms/immunology , Neoplasms/therapy , Protein Stability , Proteolysis , Proto-Oncogene Proteins c-mdm2/genetics , STAT5 Transcription Factor/genetics , Signal Transduction , Tumor Suppressor Protein p53/genetics , Tumor Suppressor Protein p53/metabolism
4.
Mol Cell ; 81(15): 3171-3186.e8, 2021 08 05.
Article in English | MEDLINE | ID: mdl-34171297

ABSTRACT

Accurate control of innate immune responses is required to eliminate invading pathogens and simultaneously avoid autoinflammation and autoimmune diseases. Here, we demonstrate that arginine monomethylation precisely regulates the mitochondrial antiviral-signaling protein (MAVS)-mediated antiviral response. Protein arginine methyltransferase 7 (PRMT7) forms aggregates to catalyze MAVS monomethylation at arginine residue 52 (R52), attenuating its binding to TRIM31 and RIG-I, which leads to the suppression of MAVS aggregation and subsequent activation. Upon virus infection, aggregated PRMT7 is disabled in a timely manner due to automethylation at arginine residue 32 (R32), and SMURF1 is recruited to PRMT7 by MAVS to induce proteasomal degradation of PRMT7, resulting in the relief of PRMT7 suppression of MAVS activation. Therefore, we not only reveal that arginine monomethylation by PRMT7 negatively regulates MAVS-mediated antiviral signaling in vitro and in vivo but also uncover a mechanism by which PRMT7 is tightly controlled to ensure the timely activation of antiviral defense.


Subject(s)
Adaptor Proteins, Signal Transducing/metabolism , Arginine/metabolism , Host-Pathogen Interactions/physiology , Immunity, Innate/physiology , Protein-Arginine N-Methyltransferases/metabolism , Adaptor Proteins, Signal Transducing/genetics , Adaptor Proteins, Signal Transducing/immunology , Animals , DEAD Box Protein 58/metabolism , Fibroblasts/virology , HEK293 Cells , Herpes Simplex/immunology , Herpes Simplex/metabolism , Herpes Simplex/virology , Humans , Methylation , Mice , Mice, Knockout , Polyunsaturated Alkamides , Protein-Arginine N-Methyltransferases/antagonists & inhibitors , Protein-Arginine N-Methyltransferases/genetics , Protein-Arginine N-Methyltransferases/immunology , Receptors, Immunologic/metabolism , Respirovirus Infections/immunology , Respirovirus Infections/metabolism , Respirovirus Infections/virology , Tripartite Motif Proteins/genetics , Tripartite Motif Proteins/metabolism , Ubiquitin-Protein Ligases/genetics , Ubiquitin-Protein Ligases/metabolism
5.
Proc Natl Acad Sci U S A ; 120(36): e2214956120, 2023 09 05.
Article in English | MEDLINE | ID: mdl-37639603

ABSTRACT

The cytosolic RNA and DNA sensors initiate type I interferon signaling when binding to RNA or DNA. To effectively protect the host against virus infection and concomitantly avoid excessive interferonopathy at resting states, these sensors must be tightly regulated. However, the key molecular mechanisms regulating these sensors' activation remain elusive. Here, we identify PRMT3, a type I protein arginine methyltransferase, as a negative regulator of cytosolic RNA and DNA sensors. PRMT3 interacts with RIG-I, MDA5, and cGAS and catalyzes asymmetric dimethylation of R730 on RIG-I, R822 on MDA5, and R111 on cGAS. These modifications reduce RNA-binding ability of RIG-I and MDA5 as well as DNA-binding ability and oligomerization of cGAS, leading to the inhibition of downstream type I interferon production. Furthermore, mice with loss of one copy of Prmt3 or in vivo treatment of the PRMT3 inhibitor, SGC707, are more resistant to RNA and DNA virus infection. Our findings reveal an essential role of PRMT3 in the regulation of antiviral innate immunity and give insights into the molecular regulation of cytosolic RNA and DNA sensors' activation.


Subject(s)
Arginine , Interferon Type I , Animals , Mice , RNA/genetics , Antiviral Agents/pharmacology , Immunity, Innate , DNA/genetics , Nucleotidyltransferases/genetics , Protein-Arginine N-Methyltransferases/genetics
6.
J Biol Chem ; 300(1): 105532, 2024 Jan.
Article in English | MEDLINE | ID: mdl-38072059

ABSTRACT

HIF1α is one of the master regulators of the hypoxia signaling pathway and its activation is regulated by multiple post-translational modifications (PTMs). Deubiquitination mediated by deubiquitylating enzymes (DUBs) is an essential PTM that mainly modulates the stability of target proteins. USP38 belongs to the ubiquitin-specific proteases (USPs). However, whether USP38 can affect hypoxia signaling is still unknown. In this study, we used quantitative real-time PCR assays to identify USPs that can influence hypoxia-responsive gene expression. We found that overexpression of USP38 increased hypoxia-responsive gene expression, but knockout of USP38 suppressed hypoxia-responsive gene expression under hypoxia. Mechanistically, USP38 interacts with HIF1α to deubiquitinate K11-linked polyubiquitination of HIF1α at Lys769, resulting in stabilization and subsequent activation of HIF1α. In addition, we show that USP38 attenuates cellular ROS and suppresses cell apoptosis under hypoxia. Thus, we reveal a novel role for USP38 in the regulation of hypoxia signaling.


Subject(s)
Hypoxia , Signal Transduction , Humans , Cell Hypoxia/genetics , Hypoxia-Inducible Factor 1, alpha Subunit/genetics , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Ubiquitin-Specific Proteases/metabolism , Ubiquitination , Cell Line
7.
J Virol ; 98(9): e0103824, 2024 Sep 17.
Article in English | MEDLINE | ID: mdl-39162481

ABSTRACT

PHD1 is a member of the prolyl hydroxylase domain protein (PHD1-4) family, which plays a prominent role in the post-translational modification of its target proteins by hydroxylating proline residues. The best-characterized targets of PHD1 are hypoxia-inducible factor α (HIF-1α and HIF-2α), two master regulators of the hypoxia signaling pathway. In this study, we show that zebrafish phd1 positively regulates mavs-mediated antiviral innate immunity. Overexpression of phd1 enhances the cellular antiviral response. Consistently, zebrafish lacking phd1 are more susceptible to spring viremia of carp virus infection. Further assays indicate that phd1 interacts with mavs through the C-terminal transmembrane domain of mavs and promotes mavs aggregation. In addition, zebrafish phd1 attenuates K48-linked polyubiquitination of mavs, leading to stabilization of mavs. However, the enzymatic activity of phd1 is not required for phd1 to activate mavs. In conclusion, this study reveals a novel function of phd1 in the regulation of antiviral innate immunity.IMPORTANCEPHD1 is a key regulator of the hypoxia signaling pathway, but its role in antiviral innate immunity is largely unknown. In this study, we found that zebrafish phd1 enhances cellular antiviral responses in a hydroxylation-independent manner. Phd1 interacts with mavs through the C-terminal transmembrane domain of mavs and promotes mavs aggregation. In addition, phd1 attenuates K48-linked polyubiquitination of mavs, leading to stabilization of mavs. Zebrafish lacking phd1 are more susceptible to spring viremia of carp virus infection. These findings reveal a novel role for phd1 in the regulation of mavs-mediated antiviral innate immunity.


Subject(s)
Adaptor Proteins, Signal Transducing , Immunity, Innate , Rhabdoviridae Infections , Rhabdoviridae , Ubiquitination , Zebrafish Proteins , Zebrafish , Animals , Zebrafish/immunology , Zebrafish Proteins/metabolism , Zebrafish Proteins/genetics , Adaptor Proteins, Signal Transducing/metabolism , Adaptor Proteins, Signal Transducing/genetics , Rhabdoviridae Infections/immunology , Hydroxylation , Humans , HEK293 Cells , Signal Transduction , Fish Diseases/immunology , Fish Diseases/virology , Protein Processing, Post-Translational
8.
Cereb Cortex ; 34(1)2024 01 14.
Article in English | MEDLINE | ID: mdl-37991273

ABSTRACT

Prolonged exposure to others' suffering can lead to empathy fatigue, especially when individuals struggle to effectively regulate their empathic capacity. Shifting active attention away from emotional components toward cognitive components of others' suffering is an effective strategy for mitigating empathy fatigue. This research investigated how top-down attentional manipulation modulates empathy fatigue in both auditory (Study 1) and visual (Study 2) modalities. Participants completed two tasks in both studies: (i) the attention to cognitive empathy task (A-C task) and (ii) the attention to emotional empathy task (A-E task). Each task included three blocks (Time Block 1, Time Block 2, and Time Block 3) designed to induce empathy fatigue. Study 1 revealed that the A-C task reduced empathy fatigue and N1 amplitudes than the A-E task in Time Block 3, indicating that attention to cognitive empathy might decrease auditory empathy fatigue. Study 2 indicates that the A-C task caused a longer N2 latency than the A-E task, signifying a decelerated emotional empathic response when attention was on cognitive empathy in the visual modality. Overall, prioritizing cognitive empathy seems to conserve mental resources and reduce empathy fatigue. This research documented the relationship between top-down attention and empathy fatigue and the possible neural mechanism.


Subject(s)
Emotions , Empathy , Humans , Emotions/physiology
9.
Nano Lett ; 24(17): 5308-5316, 2024 May 01.
Article in English | MEDLINE | ID: mdl-38647008

ABSTRACT

FAPbI3 stands out as an ideal candidate for the photoabsorbing layer of perovskite solar cells (PSCs), showcasing outstanding photovoltaic properties. Nonetheless, stabilizing photoactive α-FAPbI3 remains a challenge due to the lower formation energy of the competitive photoinactive δ-phase. In this study, we employ tetraethylphosphonium lead tribromide (TEPPbBr3) single crystals as templates for the epitaxial growth of PbI2. The strategic use of TEPPbBr3 optimizes the evolution of intermediates and the crystallization kinetics of perovskites, leading to high-quality and phase-stable α-FAPbI3 films. The TEPPbBr3-modified perovskite exhibits optimized carrier dynamics, yielding a champion efficiency of 25.13% with a small voltage loss of 0.34 V. Furthermore, the target device maintains 90% of its initial PCE under maximum power point (MPP) tracking over 1000 h. This work establishes a promising pathway through single crystal seed based epitaxial growth for achieving satisfactory crystallization regulation and phase stabilization of α-FAPbI3 perovskites toward high-efficiency and stable PSCs.

10.
Small ; 20(12): e2307042, 2024 Mar.
Article in English | MEDLINE | ID: mdl-37946682

ABSTRACT

Water stability is a crucial issue always addressed for commercial practical application of perovskite quantum dots (QDs). Recent advances in ligand engineering for in situ synthesis of water-stable perovskite QDs have attracted growing interest. However, the exact mechanism remains unclear. Here, the function of 4-bromobutyric acid (BBA) and oleylamine (OLA) is systematically studied in water-stable CsPbX3 (X = Br and I) QDs and confirms that the zwitterionic ligands generated in situ by BBA and OLA are anchored on the QDs surface, thus preventing water from penetrating into the QDs. Cs4PbBr6 intermediate crystal found in the crystal structure evolution process of CsPbX3 QD further reveals a complete crystallization process: PbX2 + CsX + Br- → Cs4PbBr6 crystals + X-→ CsPbX3 QDs + Br-. Furthermore, it is found that the solvent coordination of the precursor solution has a significant effect on the crystallinity of Cs4PbBr6 intermediate crystal, while the Rb+ doping can effectively passivate the surface defects of CsPbX3 QDs, thereby jointly achieving photoluminescence quantum yields (PLQY) of 94.6% for CsPbBr3 QDs (88.2% for CsPbI3 QDs). This work provides new insights and guiding ideas for the green synthesis of high-quality and water-stable perovskite QDs.

11.
Small ; 20(6): e2305706, 2024 Feb.
Article in English | MEDLINE | ID: mdl-37788906

ABSTRACT

Developing versatile systems that can concurrently achieve energy saving and energy generation is critical to accelerate carbon neutrality. However, challenges on designing highly effective, large scale, and multifunctional photonic film hinder the concurrent combination of passive daytime radiative cooling (PDRC) and utilization of sustainable clean energies. Herein, a versatile scalable photonic film (Ecoflex@h-BN) with washable property and excellent mechanical stability is developed by combining the excellent scattering efficiency of the hexagonal boron nitride (h-BN) nanoplates with the high infrared emissivity and ideal triboelectric negative property of the Ecoflex matrix. Strikingly, sufficiently high solar reflectance (0.92) and ideal emissivity (0.97) endow the Ecoflex@h-BN film with subambient cooling effect of ≈9.5 °C at midday during the continuous outdoor measurements. In addition, the PDRC Ecoflex@h-BN film-based triboelectric nanogenerator (PDRC-TENG) exhibits a maximum peak power density of 0.5 W m-2 . By reasonable structure design, the PDRC-TENG accomplishes effective wind energy harvesting and can successfully drive the electronic device. Meanwhile, an on-skin PDRC-TENG is fabricated to harvest human motion energy and monitor moving states. This research provides a novel design of a multifunctional PDRC photonic film, and offers a versatile strategy to realize concurrent PDRC and sustainable energies harvesting.

12.
Small ; 20(26): e2308661, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38258607

ABSTRACT

Passive daytime radiative cooling (PDRC) materials with sustainable energy harvesting capability is critical to concurrently reduce traditional cooling energy utilized for thermal comfort and transfer natural clean energies into electricity. Herein, a versatile photonic film (Ecoflex@BTO@UAFL) based on a novel fluorescent luminescence color passive radiative cooling with triboelectric and piezoelectric effect is developed by filling the dielectric BaTiO3 (BTO) nanoparticles and ultraviolet absorption fluorescent luminescence (UAFL) powder into the elastic Ecoflex matrix. Test results demonstrate that the Ecoflex@BTO@UAFL photonic film exhibits a maximum passive radiative cooling effect of ∽10.1 °C in the daytime. Meanwhile, its average temperature drop in the daytime is ~4.48 °C, which is 0.91 °C higher than that of the Ecoflex@BTO photonic film (3.56 °C) due to the addition of UAFL material. Owing to the high dielectric constant and piezoelectric effect of BTO nanoparticles, the maximum power density (0.53 W m-2, 1 Hz @ 10 N) of the Ecoflex@BTO photonic film-based hybrid nanogenerator is promoted by 70.9% compared to the Ecoflex film-based TENG. This work provides an ingenious strategy for combining PDRC effects with triboelectric and piezoelectric properties, which can spontaneously achieve thermal comfort and energy conservation, offering a new insight into multifunctional energy saving.

13.
Small ; 20(32): e2310940, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38700049

ABSTRACT

Graphene supported electrocatalysts have demonstrated remarkable catalytic performance for oxygen reduction reaction (ORR). However, their durability and cycling performance are greatly limited by Oswald ripening of platinum (Pt) and graphene support corrosion. Moreover, comprehensive studies on the mechanisms of catalysts degradation under 0.6-1.6 V versus RHE (Reversible Hydrogen Electrode) is still lacking. Herein, degradation mechanisms triggered by different defects on graphene supports are investigated by two cycling protocols. In the start-up/shutdown cycling (1.0-1.6 V vs. RHE), carbon oxidation reaction (COR) leads to shedding or swarm-like aggregation of Pt nanoparticles (NPs). Theoretical simulation results show that the expansion of vacancy defects promotes reaction kinetics of the decisive step in COR, reducing its reaction overpotential. While under the load cycling (0.6-1.0 V vs. RHE), oxygen containing defects lead to an elevated content of Pt in its oxidation state which intensifies Oswald ripening of Pt. The presence of vacancy defects can enhance the transfer of electrons from graphene to the Pt surface, reducing the d-band center of Pt and making it more difficult for the oxidation state of platinum to form in the cycling. This work will provide comprehensive understanding on Pt/Graphene catalysts degradation mechanisms.

14.
Small ; 20(35): e2401197, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38676332

ABSTRACT

Interface passivation is a key method for improving the efficiency of perovskite solar cells, and 2D/3D perovskite heterojunction is the mainstream passivation strategy. However, the passivation layer also produces a new interface between 2D perovskite and fullerene (C60), and the properties of this interface have received little attention before. Here, the underlying properties of the 2D perovskite/C60 interface by taking the 2D TEA2PbX4 (TEA = C6H10NS; X = I, Br, Cl) passivator as an example are systematically expounded. It is found that the 2D perovskite preferentially exhibits (002) orientation with the outermost surface featuring an oriented arrangement of TEACl, where the thiophene groups face outward. The outward thiophene groups further form a strong π-π stacking system with C60 molecule, strengthening the interaction force with C60 and facilitating the creation of a superior interface. Based on the vacuum-assisted blade coating, wide-bandgap (WBG, 1.77 eV) perovskite solar cells achieved impressive records of 19.28% (0.09 cm2) and 18.08% (1.0 cm2) inefficiency, respectively. This research not only provides a new understanding of interface processing for future perovskite solar cells but also lays a solid foundation for realizing efficient large-area devices.

15.
J Pharmacol Exp Ther ; 388(1): 156-170, 2024 01 02.
Article in English | MEDLINE | ID: mdl-37918855

ABSTRACT

Spleen tyrosine kinase (Syk) is an intracellular tyrosine kinase involved in the signal transduction in immune cells mainly. Its aberrant regulation is associated with diversified allergic disorders, autoimmune diseases and B cell malignancies. Therefore, inhibition of Syk is considered a reasonable approach to treat autoimmune/inflammatory diseases and B cell malignancies. Here we described the preclinical characterization of sovleplenib, a novel, highly potent and selective, oral Syk inhibitor, in several rodent autoimmune disease models. Sovleplenib potently inhibited Syk activity in a recombinant enzymatic assay and Syk-dependent cellular functions in various immune cell lines and human whole blood in vitro. Furthermore, sovleplenib, by oral administration, demonstrated strong in vivo efficacies in murine models of immune thrombocytopenia (ITP), autoimmune hemolytic anemia (AIHA), and chronic graft-versus-host disease (cGVHD), and a rat model of collagen induced arthritis (CIA) respectively, in a dose-dependent manner. Collectively, these results clearly supported sovleplenib as a therapeutic agent in the treatment of autoimmune diseases. Sovleplenib is being globally developed for ITP (Phase III, NCT05029635, Phase Ib/II, NCT03951623), wAIHA (Phase II/III, NCT05535933) and B-cell lymphoma (Phase I, NCT02857998, NCT03779113). SIGNIFICANCE STATEMENT: Syk is a key mediator of signaling pathways downstream of a wide array of receptors important for immune functions, including the B cell receptor, immunoglobulin receptors bearing Fc receptors. Inhibition of Syk could provide a novel therapeutic approach for autoimmune diseases and hematologic malignancies. The manuscript describes the preclinical pharmacology characterization of sovleplenib, a novel Syk inhibitor, in enzymatic and cellular assays in vitro and several murine autoimmune disease models in vivo.


Subject(s)
Autoimmune Diseases , Neoplasms , Rats , Mice , Humans , Animals , Protein-Tyrosine Kinases , Syk Kinase , Signal Transduction , Protein Kinase Inhibitors/pharmacology , Autoimmune Diseases/drug therapy , Neoplasms/drug therapy
16.
Drug Metab Dispos ; 52(11): 1297-1312, 2024 Oct 16.
Article in English | MEDLINE | ID: mdl-39214665

ABSTRACT

Compound probiotics have been widely used and commonly coadministered with other drugs for treating various chronic illnesses, yet their effects on drug pharmacokinetics remain underexplored. This study elucidated the impact of VSL#3 on the metabolism of probe drugs for cytochrome P450 enzymes (P450s), specifically omeprazole, tolbutamide, midazolam, metoprolol, phenacetin, and chlorzoxazone. Male Wistar rats were administered drinking water containing VSL#3 or not for 14 days and then intragastrically administered a P450 probe cocktail; this was done to investigate the host P450's metabolic phenotype. Stool, liver/jejunum, and serum samples were collected for 16S ribosomal RNA sequencing, RNA sequencing, and bile acid profiling. The results indicated significant differences in both α and ß diversity of intestinal microbial composition between the probiotic and vehicle groups in rats. In the probiotic group, the bioavailability of omeprazole increased by 269.9%, whereas those of tolbutamide and chlorpropamide decreased by 28.1% and 27.4%, respectively. The liver and jejunum exhibited 1417 and 4004 differentially expressed genes, respectively, between the two groups. In the probiotic group, most of P450 genes were upregulated in the liver but downregulated in the jejunum. The expression of genes encoding metabolic enzymes and drug transporters also changed. The serum-conjugated bile acids in the probiotic group were significantly reduced. Shorter duodenal villi and longer ileal villi were found in the probiotic group. In summary, VSL#3 administration altered the gut microbiota, host drug-processing gene expression, and intestinal structure in rats, which could be reasons for pharmacokinetic changes. SIGNIFICANCE STATEMENT: This study focused on the effects of the probiotic VSL#3 on the pharmacokinetic profile of cytochrome P450 probe drugs and the expression of host drug metabolism genes. Compared with previous studies, the present study provides a comprehensive explanation for the host drug metabolism profile modified by probiotics, combined here with the bile acid profile and histopathological analysis.


Subject(s)
Cytochrome P-450 Enzyme System , Probiotics , Animals , Male , Rats , Bile Acids and Salts/metabolism , Biological Availability , Cytochrome P-450 Enzyme System/metabolism , Gastrointestinal Microbiome/drug effects , Gastrointestinal Microbiome/physiology , Jejunum/metabolism , Jejunum/drug effects , Liver/metabolism , Liver/drug effects , Probiotics/pharmacokinetics , Probiotics/administration & dosage , Probiotics/pharmacology , Rats, Wistar
17.
Opt Lett ; 49(5): 1189-1192, 2024 Mar 01.
Article in English | MEDLINE | ID: mdl-38426970

ABSTRACT

In recent years, wide field-of-view imaging technology based on a metasurface has been widely applied. However, works on the reported sub-diffraction metalens with a wide field-of-view indicate that multiple structures are essential to effectively eliminate aberrations, which results in a heavy device thickness and weakens the advantage of an ultra-thin metasurface. To solve this problem, according to the super-oscillation theory and the translational symmetry of quadratic phase, as well as the principle of virtual aperture diaphragm based on wave vector filter, this Letter demonstrates a sub-diffraction metalens combined with a single quadratic metalens and a wave vector filter. Our design not only realizes the super-resolution effects of 0.74 to 0.75 times the diffraction limit in the wide field-of-view of nearly 180° for the first time to our knowledge but also compresses the device thickness to the subwavelength order in principle. The proposed ultra-thin sub-diffraction metalens with a wide field-of-view is expected to be applied in the fields of super-resolution fast scanning imaging, information detection, small target recognition, and so on.

18.
Opt Lett ; 49(20): 5815-5818, 2024 Oct 15.
Article in English | MEDLINE | ID: mdl-39404545

ABSTRACT

We propose a polarization superposition orthogonal theory based on tensor polarization holography. Based on this theory, the holographic multiplexing capability can be improved measurably. The orthogonality of polarization waves is characterized by the null reconstruction in polarization holography, achieved through the superposition of multiple basic polarization reference waves. This paper analyzes the orthogonality of linear polarization wave superposition and circular polarization wave superposition using the tensor polarization holography theory. Using the polarized holography multiplexing technique, we experimentally verify the orthogonality of polarization wave superposition. Our experimental results align with the theoretical analysis, indicating potential applications in polarization encoding and decoding by this theory, thereby diversifying optical encryption technology Additionally, we demonstrate that polarization superposition orthogonality holds significant promise for optical control technology.

19.
Chemphyschem ; 25(20): e202400436, 2024 Oct 16.
Article in English | MEDLINE | ID: mdl-39037893

ABSTRACT

Bioelectronic devices can be manufactured by organic-inorganic hybrid systems based on biomolecules and silicon semiconductors. The performance of the hybrid systems is largely determined by the adsorption manners of biomolecules on the silicon surface. In this paper, we demonstrated that the X-ray photoelectron spectroscopy (XPS) shake-up satellites and near-edge X-ray absorption fine-structure (NEXAFS) spectra at the carbon K-edges can be used to distinguish the interface of guanine molecules anchored on Si(100) surface. There are only 9 possible stable guanine@Si(100) hybrid systems that have been found based on the density functional theory. According to the characteristic peaks, it is confirmed that NEXAFS spectra are more sensitive to the identification of adsorption configurations. While the first characteristic peak in the low energy region of NEXAFS spectra are capable of distinguishing chemical bonds at the interface of the adsorption configurations. These results may facilitate a better understanding of the interface formations between biomolecules and silicon surfaces, which could be further utilized for the new bioelectronic device design.

20.
J Theor Biol ; 586: 111816, 2024 06 07.
Article in English | MEDLINE | ID: mdl-38589007

ABSTRACT

Immune checkpoint therapy (ICT) has greatly improved the survival of cancer patients in the past few years, but only a small number of patients respond to ICT. To predict ICT response, we developed a multi-modal feature fusion model based on deep learning (MFMDL). This model utilizes graph neural networks to map gene-gene relationships in gene networks to low dimensional vector spaces, and then fuses biological pathway features and immune cell infiltration features to make robust predictions of ICT. We used five datasets to validate the predictive performance of the MFMDL. These five datasets span multiple types of cancer, including melanoma, lung cancer, and gastric cancer. We found that the prediction performance of multi-modal feature fusion model based on deep learning is superior to other traditional ICT biomarkers, such as ICT targets or tumor microenvironment-associated markers. In addition, we also conducted ablation experiments to demonstrate the necessity of fusing different modal features, which can improve the prediction accuracy of the model.


Subject(s)
Deep Learning , Lung Neoplasms , Melanoma , Humans , Immunotherapy , Gene Regulatory Networks , Lung Neoplasms/therapy , Tumor Microenvironment
SELECTION OF CITATIONS
SEARCH DETAIL